Garlic consumption can reduce the risk of dyslipidemia: a meta-analysis of randomized controlled trials
Abstract Background and purpose Garlic is used as an important medicinal food for treatment of many diseases, however, the association between garlic consumption and dyslipidemia have yielded inconsistent results. So we carried this meta-analysis to explore the blood lipid-lowering effects of garlic...
Saved in:
Main Authors: | Yanbin Du (Author), Hua Zhou (Author), Wenting Zha (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of garlic supplementation on components of metabolic syndrome: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
by: Zhenyue Fu, et al.
Published: (2023) -
Gynostemma pentaphyllum for dyslipidemia: A systematic review of randomized controlled trials
by: Ning Dai, et al.
Published: (2022) -
Preservative effect of garlic in tomato paste can
by: S Soloty
Published: (2002) -
Adverse Effects of HMG CoA Reductase Inhibitor and Garlic on Renal Function in Patients with Diabetic Dyslipidemia
by: Naveed Ali Siddiqui, et al.
Published: (2021) -
The effect of aged garlic extract on the atherosclerotic process - a randomized double-blind placebo-controlled trial
by: Martiné Wlosinska, et al.
Published: (2020)